SHWZ Insider Trading Activity and SEC Form 4 Filings
SHWZ insider trading summary
No open-market insider purchases or sales of Medicine Man Technologies, Inc. (SHWZ) have been reported on SEC Form 4 in the past 12 months.
Latest SHWZ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 11, 2024 | Daniel Pabon | Chief Regulatory Officer | Buy | $105 (150 @ $0.70) |
| Dec 29, 2023 | Jeff Garwood | Director | Buy | $0 (15,158 @ $0.00) |
| Dec 5, 2023 | Christine Jones | Chief Legal Officer | Buy | $1K (1,880 @ $0.56) |
| Nov 29, 2023 | Forrest Hoffmaster | Chief Financial Officer | Buy | $5K (9,088 @ $0.58) |
| Nov 29, 2023 | Nirup Krishnamurthy | Chief Executive Officer | Buy | $4K (6,600 @ $0.59) |
| Nov 27, 2023 | Christine Jones | Chief Legal Officer | Buy | $1K (2,475 @ $0.60) |
| Nov 27, 2023 | Forrest Hoffmaster | Chief Financial Officer | Buy | $5K (8,000 @ $0.59) |
| Nov 21, 2023 | Forrest Hoffmaster | Chief Financial Officer | Buy | $5K (7,912 @ $0.58) |
| Nov 21, 2023 | Nirup Krishnamurthy | Chief Executive Officer | Buy | $6K (10,000 @ $0.61) |
| Sep 29, 2023 | Jeff Garwood | Director | Buy | $0 (22,152 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.